GTR 107671915

Bids Are Invited For Central Purchase - Medicines Xii - Deserts And Failure

ICB — International Competitive Bid Closed South America
Tender Information
GTR Reference
107671915
Tendering Authority
Subscribe to view
Tender No
368/2025
Financer Name
Self-Funded
Work Title
Bids Are Invited For Central Purchase - Medicines Xii - Deserts And Failure
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
30-01-2026 Closed
Work Detail
Acetylsalicylic Acid - Active Ingredient: Acetylsalicylic Acid; Concentration/Dosage: 100 Mg; Pharmaceutical Form: Liberaca Coated Tablets, Ursodeoxycholic Acid - Active Ingredient: Ursodeoxycholic Acid; Concentration/Dosage: 50 Mg; Pharmaceutical Form: Tablet; Presentation: .; Compon, Alprostadil - Active Ingredient: Alprostadil; Concentration/Dosage: 20 Mcg; Pharmaceutical Form: Lyophilized Powder For Injectable Solution; Presentation: Fra, Amikacin - Active Ingredient: Amikacin, Sulfate; Concentration/Dosage: 50 Mg/Ml; Pharmaceutical Form: Injectable Solution; Presentation: Ampoule 2 Ml; With, Aminophylline - Active Ingredient: Aminophylline; Concentration/Dosage: 100 Mg; Pharmaceutical Form: Tablet; Presentation: .; Component: .;, 01/19/2026 - 15:59:31, Asparaginase - Active Ingredient: Asparaginase; Concentration/Dosage: 10,000 Iu; Pharmaceutical Form: Freeze-Dried Powder; Presentation: Vial-Ampule; Compon, Atropine - Active Ingredient: Atropine, Sulfate; Concentration/Dosage: 0.5 Mg/Ml; Pharmaceutical Form: Injectable Solution; Presentation: 1 Ml Ampoule; Comp, Sulfate; Concentration/Dosage: 10 Mg/Ml (1%); Pharmaceutical Form: Ophthalmic Solution; Presentation: 5 Ml Bottle, Sulfate; Concentration/Dosage: 5 Mg/Ml; Pharmaceutical Form: Ophthalmic Solution; Presentation: 5 Ml Bottle; Compon, Azacitidine - Active Ingredient: Azacitidine; Concentration/Dosage: 100 Mg; Pharmaceutical Form: Powder For Injectable Suspension; Presentation: Ampoule Vial, Benzylpenicillin Benzathine - Active Ingredient: Benzylpenicillin Benzathine; Concentration/Dosage: 600,000 Iu; Pharmaceutical Form: Powder For Injection Suspension, Procaine Benzylpenicillin + Associations - Active Ingredient (1): Procaine Benzylpenicillin; Active Ingredient (2): Benzylpenicillin Potassium; Concentraca, Betamethasone - Active Ingredient: Betamethasone, Disodium Phosphate; Concentration/Dosage: 5.3 Mg/Ml; Equivalence: 4 Mg/Ml Of Betamethasone; Pharmaceutical Form, Budesonide + Associations - Active Ingredient: Budesonide + Formoterol Fumarate; Concentration/Dosage: 200 Mcg + 6 Mcg; Pharmaceutical Form: Powder Inalant, Budesonide + Associations - Active Ingredient: Budesonide + Formoterol Fumarate; Concentration/Dosage: 400 Mcg + 12 Mcg; Pharmaceutical Form: Inalan Powder, Captopril - Active Ingredient: Captopril; Concentration/Dosage: 12.5 Mg; Pharmaceutical Form: Tablet; Presentation: .; Component: .;, Calcium Carbonate - Active Ingredient: Calcium Carbonate; Concentration/Dosage: 1250 Mg; Equivalence: 500 Mg Of Elemental Calcium; Pharmaceutical Form, Cyclophosphamide - Active Ingredient: Cyclophosphamide; Concentration/Dosage: 50 Mg; Pharmaceutical Form: Coated Delayed Release Tablet; Aprese, Cinacalcet - Active Ingredient: Cinacalcet, Hydrochloride; Concentration/Dosage: 30 Mg; Pharmaceutical Form: Coated Tablet; Presentation: .; Compon, Cytarabine - Active Ingredient: Cytarabine; Concentration/Dosage: 100 Mg; Pharmaceutical Form: Injectable Solution; Presentation: 1 Ml Ampoule Bottle; Compo, Chloramphenicol - Active Ingredient: Chloramphenicol, Sodium Succinate; Concentration/Dosage: 1 G; Pharmaceutical Form: Lyophilized Powder For Injectable Solution, Chloroquine - Active Ingredient: Chloroquine Base; Concentration/Dosage: 150 Mg; Pharmaceutical Form: Tablet; Presentation: .; Component: .;, Clotrimazole - Active Ingredient: Clotrimazole; Concentration/Dosage: 10 Mg/G; Pharmaceutical Form: Dermatological Cream; Presentation: 20G Tube; Compone, Sodium Colistimethate - Active Ingredient: Sodium Colistimethate; Concentration/Dosage: 1,000.
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
707e7988-f628-47e9-9a40-21b8666d8a17.html
Attachments
Additional Details Available on Click
  • Tendering Authority
  • Publication Document (Tender Document / Tender Notice)
Disclaimer

We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.

Tell us about your Product / Services,

We will Find Tenders for you

TenderDetail
Loading tenders